Open Access. Powered by Scholars. Published by Universities.®
Social and Behavioral Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Bioethics and Medical Ethics (1)
- Biotechnology (1)
- Business (1)
- Communication (1)
- Communication Technology and New Media (1)
-
- Economics (1)
- Gender and Sexuality (1)
- Health Communication (1)
- Life Sciences (1)
- Medicine and Health (1)
- Pharmacoeconomics and Pharmaceutical Economics (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Portfolio and Security Analysis (1)
- Public Health (1)
- Science and Technology Studies (1)
- Sociology (1)
- Women's Health (1)
Articles 1 - 2 of 2
Full-Text Articles in Social and Behavioral Sciences
Where Trying To Conceive Becomes A Community Effort: A Digital Ethnography Of Online Infertility Forums, Megan Burns
Where Trying To Conceive Becomes A Community Effort: A Digital Ethnography Of Online Infertility Forums, Megan Burns
Sociology Honors Papers
Online forums for women using in vitro fertilization (IVF), or similar assisted reproductive technologies (ARTs), provide a useful setting to further evaluate and understand women’s expectations of motherhood, the relationship infertile women have with physicians and biomedicine, and their interactions on the forums. Some critics of ARTs consider them a tool of oppression in a pronatalist state. The pressure and desire to become a biological mother leads the women with access to these technologies to use them regardless. Through digital ethnographic research on four online ART forums, this research examines the intersection of altruism and self-interest in the ways forum-users …
Evaluating The Target Pipeline In A Pharmaceutical Acquisition, Daniel Vass
Evaluating The Target Pipeline In A Pharmaceutical Acquisition, Daniel Vass
Business and Economics Honors Papers
Many firms in the pharmaceutical industry turn to acquisitions when faced with gaps in their drug development pipelines and patent expirations as an alternative to making long-term investments in internal research and development. Investors are generally negative on this strategy, and upon the announcement of a pharmaceutical acquisition the stock of the acquiring firm often drops. This decline in share price creates an opportunity for the investor who can identify the characteristics of a target firm that increase the probability that the transaction will ultimately be a success, as measured by the subsequent appreciation in the acquirer's stock. It is …